Paul Lu

Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair.

Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice.

NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection.

Anti-angiogenic role of angiostatin during corneal wound healing.

Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact?

Proteome Analyst: custom predictions with explanations in a web-based tool for high-throughput proteome annotations.

Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury.

PA-GOSUB: a searchable database of model organism protein sequences with their predicted Gene Ontology molecular function and subcellular localization.

BASys: a web server for automated bacterial genome annotation.

Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury.

The Path-A metabolic pathway prediction web server.

Axon regeneration through scars and into sites of chronic spinal cord injury.

Olfactory ensheathing cells do not exhibit unique migratory or axonal growth-promoting properties after spinal cord injury.

Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor.

Checkers is solved.

Growth factors and combinatorial therapies for CNS regeneration.

Improving subcellular localization prediction using text classification and the gene ontology.

IGF-I gene delivery promotes corticospinal neuronal survival but not regeneration after adult CNS injury.

Extensive spinal decussation and bilateral termination of cervical corticospinal projections in rhesus monkeys.

GeNMR: a web server for rapid NMR-based protein structure determination.

Predicting homologous signaling pathways using machine learning.

Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury.

PROSESS: a protein structure evaluation suite and server.

HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.

Serum response factor is required for cortical axon growth but is dispensable for neurogenesis and neocortical lamination.

Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that sustain axonal regeneration: superiority to camp-mediated effects.

A critical cell-intrinsic role for serum response factor in glial specification in the CNS.

Motor axonal regeneration after partial and complete spinal cord transection.

Retarding progression of myopia with seasonal modification of topical atropine.

Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.

Integration and long distance axonal regeneration in the central nervous system from transplanted primitive neural stem cells.

Templated agarose scaffolds for the support of motor axon regeneration into sites of complete spinal cord transection.

Characterization of supraspinal vasomotor pathways and autonomic dysreflexia after spinal cord injury in F344 rats.

Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough?

Partial restoration of cardiovascular function by embryonic neural stem cell grafts after complete spinal cord transection.

Neural stem cell dissemination after grafting to CNS injury sites.

Axonal growth and connectivity from neural stem cell grafts in models of spinal cord injury.

Neural stem cells in models of spinal cord injury.

Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury.

Bridging the injured spinal cord with neural stem cells.